Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > INSM Insmed > Detailed Quotes

INSM Insmed

22.200
+0.660+3.06%
Trading Session 10/03 11:44 ET
High
22.610
Open
22.010
Turnover
3.82M
Low
21.470
Pre Close
21.540
Volume
171.29K
Market Cap
2.66B
P/E(TTM)
Loss
52wk High
34.435
Shares
119.98M
P/E(Static)
Loss
52wk Low
16.410
Float Cap
2.63B
Bid/Ask %
-20.00%
Historical High
797.500
Shs Float
118.42M
Volume Ratio
0.56
Historical Low
2.640
Dividend TTM
--
Div Yield TTM
--
P/B
60.16
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
5.29%
Avg Price
22.313
Lot Size
1
Float Cap
2.63B
Bid/Ask %
-20.00%
Historical High
797.500
Shs Float
118.42M
Volume Ratio
0.56
Historical Low
2.640
Dividend TTM
--
P/B
60.16
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
5.29%
Avg Price
22.313
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
CEO: Mr. William H. Lewis
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...